PRINCETON, N.J., June 19 /PRNewswire/ -- With pharma and biotech companies facing more and more competitive pressures, business intelligence is becoming increasingly paramount throughout the industry. The ability to gather and effectively analyze business and corporate intelligence is a major advantage for all practitioners in this industry.

Industry leaders will be gathering at the 6th Annual Pharma & Biotech Competitive Intelligence Summit, September 18-19th, 2006, in Princeton, N.J. This summit brings together a plethora of top level executives that will discuss the current issues and trends of today, announces Strategic Research Institute.

    This special program features the following:

    -- An agenda packed with trend setters and decision makers in this field.
    -- A senior-level executive panel discussion will comment on current
       challenges and trends and answer any questions posed by the audience.
    -- Attendees can express their personal views on this landscape that will
       be published in a "state of the industry" paper scheduled for future
       release in select Pharma/ Biotech publications.
    -- Numerous networking and socializing opportunities throughout the
       two-day agenda.

This year's specialists will update you on CI strategies that are successful, and how competitive intelligence's role influences and is utilized by all areas of pharma and biotech organizations. The speakers are not just from Competitive Intelligence but all areas CI is used and impacts: Strategy, Marketing, Business Analysis, Research & Development, Information Management and External Scientific Affairs.

Topics to be covered at this very unique information networking meeting include:

    -- Strategy and Intelligence:  A Case Study from Externalization
    -- Reality vs. Direction ... Is CI Congruent with the R&D Process?
    -- Manufacturing Competitive Intelligence for Pharmaceuticals
    -- Applying CI for Better In-Licensing Decisions

The complete list of participating companies and institutions include: AstraZeneca, Bayer, Biovail, Boehringer Ingelheim, Centocor, Daiichi, Ferring, Fletcher/ CSI, Genzyme, Merck, Millennium, Outward Insights, Pfizer, Shire, The Dunn Group, Wyeth

To receive the full agenda in PDF format, to register, or for information on becoming a media partner, please contact Amy Yueh of Strategic Research Institute at or , x258.

For more information on sponsorship/exhibition opportunities, please contact Amy Yueh at or , extension 258. The conference website is www.srinstitute.com/ci.

Strategic Research Institute http://www.srinstitute.com

SOURCE Strategic Research Institute